World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
8747
World Ranking
4608
National Ranking
2076

Charles E. Egwuagu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Charles E. Egwuagu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 149 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Charles E. Egwuagu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Charles E. Egwuagu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Charles E. Egwuagu is affiliated with the National Eye Institute in the United States and focuses on the study of immunology, ophthalmology, and related biomedical fields. Their research portfolio spans multiple interconnected disciplines, particularly in immunology and microbiology as well as medicine.

Their scientific contributions address key topics such as:

  • Immunotherapy and immune responses
  • Ocular diseases and Behçet's syndrome
  • Systemic lupus erythematosus research
  • T-cell and B-cell immunology
  • Cytokine signaling pathways and interactions
  • Interferon and immune responses
  • Psoriasis: treatment and pathogenesis

Egwuagu's frequent publication venues include:

  • Frontiers in Immunology
  • International Journal of Molecular Sciences
  • Proceedings of the National Academy of Sciences
  • Journal of Molecular Biology
  • Scientific Reports

Among recent papers authored or co-authored by Egwuagu are:

  • "Uveitis: Molecular Pathogenesis and Emerging Therapies," 2021, Frontiers in Immunology
  • "Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis," 2020, Frontiers in Immunology
  • "IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases," 2021, Proceedings of the National Academy of Sciences
  • "Interleukin 35 Regulatory B Cells," 2020, Journal of Molecular Biology
  • "STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs," 2020, Scientific Reports

Egwuagu frequently collaborates with other researchers in their field. Notable co-authors include:

  • Jin Kyeong Choi
  • Cheng-Rong Yu
  • Evaristus C. Mbanefo
  • Min-Kyung Kang
  • Manoj Kumar Yadav

The scope of Egwuagu's work contributes to a better understanding of immune mechanisms underlying ocular and systemic autoimmune diseases, with emphasis on cytokine signaling and regulatory functions of immune cells. The research supports multidisciplinary approaches drawn from immunology, ophthalmology, molecular biology, rheumatology, and oncology.

Best Publications

  • TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

    Ahjoku Amadi-Obi;Cheng-Rong Yu;Xuebin Liu;Rashid M Mahdi

  • Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

    Ren-Xi Wang;Cheng-Rong Yu;Ivy M Dambuza;Rashid M Mahdi

  • Suppressors of Cytokine Signaling Proteins Are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance

    Charles E. Egwuagu;Cheng-Rong Yu;Meifen Zhang;Rashid M. Mahdi

  • Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases

    Xuebin Liu;Yun Sang Lee;Cheng-Rong Yu;Charles E. Egwuagu

  • STAT3 in CD4+ T helper Cell differentiation and Inflammatory Diseases

    Charles E. Egwuagu

  • Thymic expression of autoantigens correlates with resistance to autoimmune disease.

    C E Egwuagu;P Charukamnoetkanok;I Gery

  • Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease

    Lin Sun;Chang He;Lekha Nair;Justine Yeung

  • Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.

    Sharon H. Jackson;Cheng-Rong Yu;Rashid M. Mahdi;Samuel Ebong

  • IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.

    Ivy M. Dambuza;Chang He;Chang He;Jin Kyeong Choi;Cheng-Rong Yu

  • A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.

    Xiaoqian Wang;Yinxiang Wei;He Xiao;Xiaoling Liu

  • Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception

    Nicolas Vogel;Michael Kirisits;Eric Michael;Howard Bach

  • Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells.

    Cheng-Rong Yu;Rashid M. Mahdi;Samuel Ebong;Barbara P. Vistica

  • STAT3 Protein Interacts with Class O Forkhead Transcription Factors in the Cytoplasm and Regulates Nuclear/Cytoplasmic Localization of FoxO1 and FoxO3a Proteins in CD4+ T Cells

    Hyun-Mee Oh;Cheng-Rong Yu;Ivy Dambuza;Bernadette Marrero

  • STAT3 Protein Promotes T-cell Survival and Inhibits Interleukin-2 Production through Up-regulation of Class O Forkhead Transcription Factors

    Hyun-Mee Oh;Cheng-Rong Yu;Nady Golestaneh;Ahjoku Amadi-Obi

  • Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.

    Charles E. Egwuagu;Cheng-Rong Yu;Lin Sun;Renxi Wang

  • Novel IL27p28/IL12p40 Cytokine Suppressed Experimental Autoimmune Uveitis by Inhibiting Autoreactive Th1/Th17 Cells and Promoting Expansion of Regulatory T Cells

    Ren-Xi Wang;Cheng-Rong Yu;Rashid M. Mahdi;Charles E. Egwuagu

  • Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10.

    Yun Sang Lee;Ahjoku Amadi-Obi;Cheng-Rong Yu;Charles E Egwuagu

  • STAT3 Activates miR-155 in Th17 Cells and Acts in Concert to Promote Experimental Autoimmune Uveitis

    Thelma Escobar;Cheng-Rong Yu;Stefan A. Muljo;Charles E. Egwuagu

  • Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling.

    Cheng-Rong Yu;Rashid M. Mahdi;Samuel Ebong;Barbara P. Vistica

  • Autoreactive Memory CD4+ T Lymphocytes that mediate Chronic Uveitis Reside in the Bone Marrow through STAT3-dependent Mechanisms

    Hyun-Mee Oh;Cheng-Rong Yu;YongJun Lee;Chi-Chao Chan

  • Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals

    Hiroshi Takase;Cheng Rong Yu;Rashid M. Mahdi;Daniel C. Douek

Frequent Co-Authors

Igal Gery
Igal Gery National Institutes of Health
Chi-Chao Chan
Chi-Chao Chan National Institutes of Health
Rachel R. Caspi
Rachel R. Caspi National Institutes of Health
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
Eric F. Wawrousek
Eric F. Wawrousek National Institutes of Health
Eddie Reed
Eddie Reed National Institutes of Health
Paul T. Wingfield
Paul T. Wingfield National Institutes of Health
Vilhelm A. Bohr
Vilhelm A. Bohr University of Copenhagen
Robert N. Fariss
Robert N. Fariss National Institutes of Health
Jun Chen
Jun Chen Sun Yat-sen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining immunology with advanced healthcare roles, exploring various nursing degrees and career paths can be highly beneficial. Many students consider accelerated options, such as the nurse practitioner accelerated program, which efficiently prepares candidates for high-demand nursing positions.

Transitioning between nursing specialties is also a common pathway. For example, professionals looking to broaden their scope might follow guidance on how to fnp to acute care np, enabling them to provide acute care services while leveraging their family nurse practitioner skills.

Online options remain popular for non-traditional students or career changers. Programs like online rn programs for non nurses in Florida offer flexible entry points into nursing, which can complement immunology expertise in clinical settings.

Lastly, understanding financial prospects is crucial. Resources such as the dnp salary by state provide valuable insights for advanced practice nurses considering the Doctor of Nursing Practice degree, helping them make informed career and education decisions related to immunology and healthcare.

Best Scientists Citing Charles E. Egwuagu

Trending Scientists

Recently Published Articles